Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  News

News

Latest NewsCompaniesMarketsEconomy & ForexCommoditiesInterest RatesHot NewsMost Read NewsRecomm.Business LeadersCalendar 

Burzynski Clinic Presents Over Five Years Survival Data From Phase II Trials of ANP for Inoperable Brain Tumors at the Congress

share with twitter share with LinkedIn share with facebook
share via e-mail
0
11/16/2013 | 03:34am CET

The Burzynski Clinic (BC) announced today that it made a keynote speaker presentation at the 2nd Annual Congress of Asia-Pacific Academy of Anti-Aging Medicine in Beijing, China. Based on the presentation in Beijing, a total of 401 eligible patients (patients who received over 28 days of treatment) with advanced inoperable brain tumors have been treated with antineoplaston A10 and antineoplastons AS2-1 therapy (ANP) in phase II studies. Most of the patients (87%) were diagnosed with high-grade tumors and the remaining patients were diagnosed with low-grade tumors. The patients were diagnosed by pathologists not associated with BC and objective responses were verified by Central Radiology Review. The group of 77 patients (19%) survived over five years from the treatment start. Of particular interest were results in patients with brainstem gliomas. The group of 17 patients with brainstem glioma underwent the treatment and 65% of these patients survived over five years. An additional group of 42 patients diagnosed with diffuse intrinsic pontine glioma (DIPG) have been treated and a total of 19% survived over five years.

The quality of survival is very good and there is no long-term toxicity related to ANP.

These clinical results are very encouraging, since they describe a positive ANP effect on some of the worst malignancies in the entire oncology field, but they will require FDA approval.

Burzynski Clinic is committed to developing treatments for cancer based on genomic and epigenomic principles.

Forward-looking statements in this release are made pursuant to the safe harbor provisions of the federal securities laws. Information contained in forward-looking statements is based on current expectations and is subject to change, and future events may differ materially from those discussed herein due to a number of factors, including, but not limited to, risks and uncertainties related to the clinic's ability to use Antineoplastons A10 and AS2-1. Burzynski Clinic does not undertake to update any such forward-looking statements or to publicly announce developments or events relating to the matters described herein.

For Burzynski Clinic
Carolyn Powers, 713-335-5664
carolyn@burzynskiclinic.com


© Business Wire 2013
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news
Date Title
07:43p CISCO : How can OTT keep your customers coming back?
07:41p TECHNOGYM : 10 of the UAE’s most luxurious gyms
07:33p Buffett mulls change to canny Bank of America stake if dividend rises
07:33p Buffett upbeat on American business; Berkshire operating profit down
07:32p BERKSHIRE HATHAWAY : Buffett calls Clayton Homes unit 'best-in-class' despite critics
07:31p APPLE : Berkshire Hathaway gains $1.6 billion from its huge bite of Apple
07:31p Buffett upbeat on American business; Berkshire operating profit down
07:23p BEAUFIELD RESOURCES : Responds to Misleading Press Release Issued by Deluce/Shanghai Huaxin Group
07:22p BEAUFIELD RESOURCES : Responds to Misleading Press Release Issued by Deluce/Shanghai Huaxin Group
07:17p INOTEK PHARMACEUTICALS CORP : Khang & Khang LLP Announces Securities Class Action Lawsuit against Inotek Pharmaceuticals Corporation and Encourages Investors with Losses to Contact the Firm
Latest news
Advertisement
Hot News 
-5.13%Baidu posts bleak fourth quarter, but sees business reshuffle driving 2017 growth
-3.94%VIVENDI : Shares Hit Hard by Fall in Profit -- 2nd Update
-5.77%Property website Rightmove generates fewer client leads in 2016
-5.83%J.C. Penney holiday quarter sales drop, to shut 130-140 stores
-8.22%Canada's MacDonald Dettwiler to buy satellite imagery firm DigitalGlobe
Most Read News
01:31p APPLE : Berkshire Hathaway gains $1.6 billion from its huge bite of Apple
08:27aDJBuffett's Berkshire Hathaway Reports Rise in Net Earnings
02/24 Blake Insomnia Therapeutics Inc. Closes Joint Venture with Sajo Consulting LLC
02/24 Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Egalet Corporation of Class Action Lawsuit and Upcoming Deadline - EGLT
02/24DJCITIGROUP : Confirms Investigations Over 'Princelings' Hiring Practices
Most recommended articles
02/23DJVIVENDI : Full-Year Earnings Beat Estimates
01:33p Buffett mulls change to canny Bank of America stake if dividend rises
01:33p Buffett upbeat on American business; Berkshire operating profit down
01:32p BERKSHIRE HATHAWAY : Buffett calls Clayton Homes unit 'best-in-class' despite critics
09:34aDJMARKET SNAPSHOT : Why The Stock Market's Tight Trading Range Isn't Worrying Wall Street Yet